ATE312187T1 - Durch entzündungsvermittler induzierbare hybridpromotoren, diese enthaltende vektoren und verwendungen davon - Google Patents

Durch entzündungsvermittler induzierbare hybridpromotoren, diese enthaltende vektoren und verwendungen davon

Info

Publication number
ATE312187T1
ATE312187T1 AT01914000T AT01914000T ATE312187T1 AT E312187 T1 ATE312187 T1 AT E312187T1 AT 01914000 T AT01914000 T AT 01914000T AT 01914000 T AT01914000 T AT 01914000T AT E312187 T1 ATE312187 T1 AT E312187T1
Authority
AT
Austria
Prior art keywords
promotors
inducible
inflammation
hybrid
vectors containing
Prior art date
Application number
AT01914000T
Other languages
English (en)
Inventor
Charbel Massaad
Francis Berenbaum
Jean-Luc Olivier
Colette Salvat
Gilbert Bereziat
Original Assignee
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0003262A external-priority patent/FR2806418B1/fr
Application filed by Univ Paris Curie filed Critical Univ Paris Curie
Application granted granted Critical
Publication of ATE312187T1 publication Critical patent/ATE312187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01914000T 2000-03-14 2001-03-14 Durch entzündungsvermittler induzierbare hybridpromotoren, diese enthaltende vektoren und verwendungen davon ATE312187T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0003262A FR2806418B1 (fr) 2000-03-14 2000-03-14 Promoteurs hybrides inductibles par l'inflammation, vecteurs les contenant et utilisations
US19695900P 2000-04-13 2000-04-13
PCT/FR2001/000759 WO2001068845A2 (fr) 2000-03-14 2001-03-14 Promoteurs hybrides inductibles par l'inflammation, vecteurs les contenant et utilisations

Publications (1)

Publication Number Publication Date
ATE312187T1 true ATE312187T1 (de) 2005-12-15

Family

ID=26212255

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01914000T ATE312187T1 (de) 2000-03-14 2001-03-14 Durch entzündungsvermittler induzierbare hybridpromotoren, diese enthaltende vektoren und verwendungen davon

Country Status (9)

Country Link
EP (1) EP1263978B1 (de)
JP (1) JP2003526368A (de)
AT (1) ATE312187T1 (de)
AU (1) AU2001239392A1 (de)
CA (1) CA2403189A1 (de)
DE (1) DE60115610T2 (de)
DK (1) DK1263978T3 (de)
ES (1) ES2254378T3 (de)
WO (1) WO2001068845A2 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2269897A (en) * 1992-08-13 1994-02-23 Merck Frosst Canada Inc Assay to detect peroxisome proliferator activity
FR2755699B1 (fr) * 1996-11-08 1998-12-18 Rhone Poulenc Rorer Sa Nouvelles constructions et vecteurs pour l'expression ciblee et inductible des genes
US5925657A (en) * 1997-06-18 1999-07-20 The General Hospital Corporation Use of PPARγ agonists for inhibition of inflammatory cytokine production
CN1370240A (zh) * 1999-06-22 2002-09-18 阿文蒂斯药物股份有限公司 利用ppar核受体的表达调节系统

Also Published As

Publication number Publication date
EP1263978B1 (de) 2005-12-07
EP1263978A2 (de) 2002-12-11
DE60115610D1 (de) 2006-01-12
DE60115610T2 (de) 2006-10-19
AU2001239392A1 (en) 2001-09-24
WO2001068845A2 (fr) 2001-09-20
DK1263978T3 (da) 2006-04-18
ES2254378T3 (es) 2006-06-16
JP2003526368A (ja) 2003-09-09
CA2403189A1 (fr) 2001-09-20
WO2001068845A3 (fr) 2002-02-28

Similar Documents

Publication Publication Date Title
Biswas et al. Role of Nrf1 in antioxidant response element-mediated gene expression and beyond
Ott et al. vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression
Toft et al. Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression
KR950700995A (ko) 조절 신호인 지방체(oil-body) 단백질 시스-요소(cis-element)(OIL-BODY PROTEIN CIS-ELEMENTS AS REGULATORY SIGNALS)
ATE225853T1 (de) Gewebe-spezifische promotoren
DE602004031041D1 (de) In pflanzenplastiden funktionsfähiger promotor
WO2001036623A3 (en) Ecdysone-inducible adeno-associated virus expression vectors
Mahony et al. Oncostatin M and kit-ligand control hematopoietic stem cell fate during zebrafish embryogenesis
Wong et al. Selective and transient in vitro effects of heat shock on alveolar type II cell gene expression
ATE312187T1 (de) Durch entzündungsvermittler induzierbare hybridpromotoren, diese enthaltende vektoren und verwendungen davon
DE69618574T2 (de) Vom desmingen abstammende amplifizierungssequenzen, vektoren, die diese enthalten und anwendungen derselben zur herstellung von proteinen
Hsieh et al. Regulation of basal and luminal cell-specific cytokeratin expression in rat accessory sex organs. Evidence for a new class of androgen-repressed genes and insight into their pairwise control.
WO2004033653A3 (en) Gene regulation with aptamer and modulator complexes for gene therapy
ATE535543T1 (de) Aus dem neurotensin-rezeptor 3 entwickeltes peptid und seine verwendung bei der behandlung psychischer krankheiten
HUP9904235A2 (hu) Új szerkezetek és vektorok gének célzott és indukálható kifejezésére
TW200610766A (en) A liver-specific chimeric regulatory sequence and use thereof
MXPA05006983A (es) Promotor artificial para la expresion de secuencias de acido desoxirribonucleico en celulas vegetales.
Martin Learning from vascular remodelling.
ES2181684T3 (es) Promotor del gen epidermico humano.
MXPA03005039A (es) Secuencias anteriores al gen prac, vectores que las contienen y usos de las mismas.
AR032686A1 (es) Elementos reguladores adecuados para usar en la expresion genetica
ATE481495T1 (de) Adenovirusvektor
ATE472603T1 (de) Atrsp gen promotoren
JFR et al. Novel viral vectors based on transcriptional amplification strategy and bidirectional cell-specific mammalian promoters
Au et al. In vivo functional analysis of SOX9 by conditional expression of a mutant Sox9, Sox9Y440X, in the notochord.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1263978

Country of ref document: EP

REN Ceased due to non-payment of the annual fee